表紙
市場調査レポート

市中細菌性肺炎:世界の治験レビュー

Community-Acquired Bacterial Pneumonia Global Clinical Trials Review, H2, 2014

発行 GlobalData 商品コード 320828
出版日 ページ情報 英文 111 Pages
即納可能
価格
本日の銀行送金レート: 1USD=102.12円で換算しております。
Back to Top
市中細菌性肺炎:世界の治験レビュー Community-Acquired Bacterial Pneumonia Global Clinical Trials Review, H2, 2014
出版日: 2014年11月30日 ページ情報: 英文 111 Pages
概要

市中細菌性肺炎は、胸痛、咳、痰の産生、呼吸困難、寒気、悪寒、発熱、または低血圧症に関連する、肺実質の急性細菌感染として定義され、胸部X線画像では、新たな肺葉または多葉性浸潤の存在を伴います。市中細菌性肺炎を引き起こす、代表的な細菌性病原体は、肺炎球菌、インフルエンザ菌、モラクセラ・カタラーリスなどです。また、クラミジア・ニューモニエ、マイコプラズマ・ニューモニエ、レジオネラ・ニューモフィラなど、典型的な細菌性病原体も、市中細菌性肺炎を引き起こします。

当レポートでは、市中細菌性肺炎の治療薬に関する治験について調査分析し、治験数および被験者数、段階別・相別の状況、有望企業、開発中の治療薬の情報、治験プロファイルなどについて、体系的な情報を提供しています。

目次

イントロダクション

地域別の治験

  • 国別の治験動向
    • アジア太平洋地域の主要国
    • 欧州の主要国
    • 北米の主要国
    • 中東・アフリカの主要国
    • 中南米の主要国

G7諸国における治験:感染性疾患の治験に対する市中細菌性肺炎の割合

G7諸国における治験:相別

G7諸国における治験:段階別

E7諸国における治験:感染性疾患の治験に対する市中細菌性肺炎の割合

E7諸国における治験:相別

E7諸国における治験:段階別

相別の治験

段階別の治験

評価項目別の治験

未完了の治験

一定期間に採用された被験者

スポンサータイプ別の治験

有望なスポンサー

  • 市中細菌性肺炎の治療薬の治験に参加している主要企業

有望薬

治験プロファイル

  • 主要企業の治験概要
    • Actavis plc
    • Cempra, Inc.
    • Pfizer Inc.
    • Cempra Pharmaceuticals, Inc.
    • AstraZeneca PLC
    • Nabriva Therapeutics AG
    • Cubist Pharmaceuticals, Inc.
    • Boehringer Ingelheim Auslandsbeteiligungs GmbH
    • Bayer AG
    • Basilea Pharmaceutica AG
  • 主要大学・研究機関・病院の治験概要
    • 横浜労災病院
    • Nagasaki Evaluation Organization for Clinical Interventions(NEOCI)
    • 中日本呼吸器臨床研究機構(CJLSG)
    • Albany Medical Center

主な臨床プロファイル

付録

図表

目次
Product Code: GDHC2441CTIDB

GlobalData's clinical trial report, "Community-Acquired Bacterial Pneumonia Global Clinical Trials Review, H2, 2014" provides data on the Community-Acquired Bacterial Pneumonia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Community-Acquired Bacterial Pneumonia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Community-Acquired Bacterial Pneumonia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Community-Acquired Bacterial Pneumonia
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Community-Acquired Bacterial Pneumonia to Infectious Disease Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Community-Acquired Bacterial Pneumonia to Infectious Disease Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Community-Acquired Bacterial Pneumonia
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Community-Acquired Bacterial Pneumonia Therapeutics Clinical Trials
  • Prominent Drugs
  • Latest Clinical Trials News on Community-Acquired Bacterial Pneumonia
    • Sep 25, 2014: Cempra Completes Enrollment of Solitaire-Oral Phase 3 Trial
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Actavis plc
      • Clinical Trial Overview of Actavis plc
      • Cempra, Inc.
      • Clinical Trial Overview of Cempra, Inc.
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • Cempra Pharmaceuticals, Inc.
      • Clinical Trial Overview of Cempra Pharmaceuticals, Inc.
      • AstraZeneca PLC
      • Clinical Trial Overview of AstraZeneca PLC
      • Nabriva Therapeutics AG
      • Clinical Trial Overview of Nabriva Therapeutics AG
      • Cubist Pharmaceuticals, Inc.
      • Clinical Trial Overview of Cubist Pharmaceuticals, Inc.
      • Boehringer Ingelheim Auslandsbeteiligungs GmbH
      • Clinical Trial Overview of Boehringer Ingelheim Auslandsbeteiligungs GmbH
      • Bayer AG
      • Clinical Trial Overview of Bayer AG
      • Basilea Pharmaceutica AG
      • Clinical Trial Overview of Basilea Pharmaceutica AG
    • Clinical Trial Overview of Top Institutes / Government
      • Yokohama Rosai Hospital
      • Clinical Trial Overview of Yokohama Rosai Hospital
      • Nagasaki Evaluation Organization for Clinical Interventions
      • Clinical Trial Overview of Nagasaki Evaluation Organization for Clinical Interventions
      • Central Japan Lung Study Group
      • Clinical Trial Overview of Central Japan Lung Study Group
      • Albany Medical Center
      • Clinical Trial Overview of Albany Medical Center
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Community-Acquired Bacterial Pneumonia Therapeutics, Global, Clinical Trials by Region, 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014*
  • Proportion of Community-Acquired Bacterial Pneumonia to Infectious Disease Clinical Trials, G7 Countries (%), 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Community-Acquired Bacterial Pneumonia to Infectious Disease Clinical Trials, E7 Countries (%), 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Community-Acquired Bacterial Pneumonia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Actavis plc, 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Cempra, Inc., 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Cempra Pharmaceuticals, Inc., 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Nabriva Therapeutics AG, 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Cubist Pharmaceuticals, Inc., 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Boehringer Ingelheim Auslandsbeteiligungs GmbH, 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Basilea Pharmaceutica AG, 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Yokohama Rosai Hospital, 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Nagasaki Evaluation Organization for Clinical Interventions, 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Central Japan Lung Study Group, 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Albany Medical Center, 2014*

List of Figures

  • Community-Acquired Bacterial Pneumonia Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014*
  • Proportion of Community-Acquired Bacterial Pneumonia to Infectious Disease Clinical Trials, G7 Countries (%), 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Community-Acquired Bacterial Pneumonia to Infectious Disease Clinical Trials, E7 Countries (%), 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Community-Acquired Bacterial Pneumonia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Community-Acquired Bacterial Pneumonia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top